Results: Nearly one third of the sample (32.8%) reported lifetime nonmedical use of sedative-hypnotics or opiates: 27.9% sedative-hypnotics, and 19.2% opiates. Prior lifetime victimization was common in the sample. The results of logistic regression indicate the overall model was statistically reliable (χ2 = 182.408, df = 11, p < .001) and the Nagelkerke R2 = .304. Women from the rural communities were 1.7 times more likely to use nonmedically sedative-hypnotics and opiates than women from the urban community. Women who used other illicit drugs in the past 12 months were 4.3 times more likely to report lifetime nonmedical use of sedative-hypnotics and opiates. Women who met criteria for alcohol abuse or dependence were 1.6 times more likely to report lifetime nonmedical use of sedative-hypnotics and opiates. Cumulative lifetime victimization index and unmet health care needs were positively associated, while age was negatively associated with nonmedical use of sedative-hypnotics and opiates. None of the indices for recent IPV were associated with nonmedical use of sedative-hypnotics and opiates.
Conclusions and Implications: Lifetime rates of nonmedical use of sedative-hypnotics and opiates were higher in this sample of recent partner violence victims, particularly in the rural, Appalachian area, than in the general population in the state. Cumulative lifetime exposure to victimization was a significant risk factor for nonmedical use of sedative-hypnotics and opiates.
The study findings have implications for substance abuse prevention and treatment. Women with multiple types of victimization should be targeted for substance abuse prevention efforts (SAMHSA, 1997). Substance abuse treatment programs have an opportunity to address lifetime victimization experiences and their role as a risk factor for substance use, in general, and specifically nonmedical use of sedative-hypnotics and opiates. Greater linkages and collaboration between domestic violence programs and substance abuse treatment programs are needed to overcome the numerous barriers that impede the effective treatment of substance abuse and appropriate response to women experiencing both problems (Logan et al., 2002; SAMHSA, 1997).